BioCat GmbH
... offers a wide range of high-quality research reagents as well as cutting-edge technologies in the fields of genomics, proteomics, and cell biology (D) [e]
Biotrend
... is specialised in Immunology, Neuroscience, Pharmacology and Radiochemistry, supplying biomedical and pharmaceutical research with a large range of antibodies, radiolabelled products, custom synthesis and antibody production services (D) [d, e]
CE-Immundiagnostika GmbH
Blood grouping tests serums, serum products, blood plasma products, polyclonal and monoclonal antibodies (D) [d, e, f]
The author- or copyrights of the listed Internet pages
are held by the respective authors or site operators, who are also responsible
for the content of the presentations.
-
To add your site to this index please send us a
eMail.
The New Edition of this popular text features world-renowned experts who offer the most current information and reliable guidance on immunohistochemical diagnoses in surgical pathology and cytopathology. The book is organized in a consistent format of organ systems, specifically designed to target diagnostic dilemmas in surgical pathology. Each chapter features an introduction and a systematic approach to the diagnostic entities of that organ system. Readers will also find easy-to-understand diagnostic algorithms and immunohistograms that depict immunostaining patterns of tumors, as well as charts, tables, and high-quality color histologic images that assist in making a definitive diagnosis. Churchill Livingstone, 2002.
A core collection of diverse cutting-edge techniques for the generation, expression, optimization, and characterization of recombinant antibodies. Readily reproducible protocols for lead generation range from the cloning of human immunoglobulin genes to the selection and generation of human recombinant antibodies by humanization approaches, molecular display technologies and transgenic animals. Procedures are also described on restructuring antibody leads into monovalent, multivalent, and bispecific binding fragments for a wide variety of in vivo applications. State-of-the-art technologies are described for the characterization of antigen-binding affinity and specificity with novel applications in radioimmunotargeting, cancer immunotherapy, drug abuse, and proteomics. Humana Press 2003.
